RU2018136939A - Применение пробиотиков для лечения и/или профилактики псориаза - Google Patents
Применение пробиотиков для лечения и/или профилактики псориаза Download PDFInfo
- Publication number
- RU2018136939A RU2018136939A RU2018136939A RU2018136939A RU2018136939A RU 2018136939 A RU2018136939 A RU 2018136939A RU 2018136939 A RU2018136939 A RU 2018136939A RU 2018136939 A RU2018136939 A RU 2018136939A RU 2018136939 A RU2018136939 A RU 2018136939A
- Authority
- RU
- Russia
- Prior art keywords
- psoriasis
- lactis
- longum
- use according
- rhamnosus
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title claims 14
- 239000006041 probiotic Substances 0.000 title claims 9
- 235000018291 probiotics Nutrition 0.000 title claims 9
- 230000002265 prevention Effects 0.000 title claims 3
- 239000000203 mixture Substances 0.000 claims 12
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims 8
- 241001608472 Bifidobacterium longum Species 0.000 claims 8
- 230000000529 probiotic effect Effects 0.000 claims 8
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims 7
- 244000005700 microbiome Species 0.000 claims 4
- 239000003826 tablet Substances 0.000 claims 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 235000015872 dietary supplement Nutrition 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 235000016709 nutrition Nutrition 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- -1 sachets Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 241001134770 Bifidobacterium animalis Species 0.000 claims 1
- 241000131482 Bifidobacterium sp. Species 0.000 claims 1
- 206010015278 Erythrodermic psoriasis Diseases 0.000 claims 1
- 241000170280 Kluyveromyces sp. Species 0.000 claims 1
- 241000186610 Lactobacillus sp. Species 0.000 claims 1
- 206010028703 Nail psoriasis Diseases 0.000 claims 1
- 206010037575 Pustular psoriasis Diseases 0.000 claims 1
- 241000235088 Saccharomyces sp. Species 0.000 claims 1
- 241000194022 Streptococcus sp. Species 0.000 claims 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 claims 1
- 229940118852 bifidobacterium animalis Drugs 0.000 claims 1
- 235000013339 cereals Nutrition 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 239000007910 chewable tablet Substances 0.000 claims 1
- 229940112822 chewing gum Drugs 0.000 claims 1
- 235000015218 chewing gum Nutrition 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 235000015140 cultured milk Nutrition 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 235000013350 formula milk Nutrition 0.000 claims 1
- 235000015203 fruit juice Nutrition 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 235000015243 ice cream Nutrition 0.000 claims 1
- 239000007937 lozenge Substances 0.000 claims 1
- 235000013622 meat product Nutrition 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 210000004761 scalp Anatomy 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 235000015192 vegetable juice Nutrition 0.000 claims 1
- 235000013618 yogurt Nutrition 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Claims (15)
1. Применение пробиотической композиции, содержащей Bifidobacterium animalis subsp. lactis (В. lactis), Bifidobacterium longum и Lactobacillus rhamnosus, для лечения и/или предупреждения вспышек псориаза и/или псориаза.
2. Применение по п. 1, причем В. lactis представляет собой В. lactis СЕСТ 8145, В. longum представляет собой В. longum ES1 СЕСТ 7347 и/или L. rhamnosus представляет собой L. rhamnosus СЕСТ 8361.
3. Применение по п. 1 или п. 2, причем вспышка псориаза или псориаз выбраны из группы, состоящей из пятнистого (бляшечного) псориаза, ладонно-подошвенного псориаза (пальмо-плантарного псориаза), псориаза волосистой части головы, псориаза ногтей, псориаза на лице, обратного (инверсионного) псориаза, поражающего кожные складки, каплевидного псориаза, эритродермического псориаза и пустулезного псориаза.
4. Применение по п. 1, причем пробиотическая композиция является фармацевтической композицией или питательной композицией.
5. Применение по п. 4, причем пробиотическая композиция содержит фармацевтически приемлемый носитель и/или эксципиент.
6. Применение по п. 4, причем пробиотическая композиция приготовлена для введения в виде жидкой формы или в виде твердой формы.
7. Применение по п. 6, причем твердая форма выбрана из группы, состоящей из таблеток, леденцов для рассасывания, сладких подушечек, жевательных таблеток, жевательной резинки, капсул, саше, порошков, гранул, частиц с покрытием или таблеток с покрытием, таблеток, покрытых кишечнорастворимой оболочкой, и капсул и диспергируемых плоских полосок и пленок.
8. Применение по п. 6, причем жидкая форма выбрана из группы, состоящей из пероральных растворов, суспензий, эмульсий и сиропов.
9. Применение по п. 4, причем питательная композиция представляет собой пищевую или питательную добавку.
10. Применение по п. 9, причем пища выбирается из группы, состоящей из фруктовых или овощных соков, мороженого, детских смесей, молока, йогурта, сыра, ферментированного молока, порошкового молока, круп, хлебобулочных изделий, молочных продуктов, мясных продуктов и напитков.
11. Применение по п. 1, причем пробиотическая композиция дополнительно содержит микроорганизм, выбранный из группы, состоящей из Lactobacillus sp., Streptococcus sp., Bifidobacterium sp., Saccharomyces sp., Kluyveromyces sp. и их комбинаций.
12. Применение по п. 1, причем общая концентрация микроорганизмов штаммов В. lactis, L. rhamnosus и В. longum в композиции составляет между 103 и 1012 КОЕ, предпочтительно, 109 КОЕ.
13. Пробиотическая композиция, содержащая микроорганизмы Bifidobacterium animalis subs. lactis (В. lactis), Bifidobacterium longum и Lactobacillus rhamnosus, причем концентрация В. longum в расчете на общую концентрацию микроорганизмов, присутствующих в композиции, составляет по меньшей мере 30%, предпочтительно, по меньшей мере 35%.
14. Пробиотическая композиция по п. 13, в которой В. lactis представляет собой В. lactis СЕСТ 8145, В. longum представляет собой В. longum ESI СЕСТ 7347 и/или L. rhamnosus представляет собой L. rhamnosus СЕСТ 8361.
15. Применение пробиотической композиции по п. 14 для лечения и/или предупреждения вспышек псориаза и/или псориаза.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382122.6A EP3222282A1 (en) | 2016-03-21 | 2016-03-21 | Use of probiotics in the treatment and/or prevention of psoriasis |
| EP16382122.6 | 2016-03-21 | ||
| PCT/EP2017/056719 WO2017162683A1 (en) | 2016-03-21 | 2017-03-21 | Use of probiotics in the treatment and/or prevention of psoriasis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018136939A true RU2018136939A (ru) | 2020-04-22 |
| RU2018136939A3 RU2018136939A3 (ru) | 2020-05-13 |
| RU2767967C2 RU2767967C2 (ru) | 2022-03-23 |
Family
ID=55969084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018136939A RU2767967C2 (ru) | 2016-03-21 | 2017-03-21 | Применение пробиотиков для лечения и/или профилактики псориаза |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10912802B2 (ru) |
| EP (2) | EP3222282A1 (ru) |
| KR (1) | KR102303587B1 (ru) |
| CN (1) | CN110325198B (ru) |
| AR (1) | AR107921A1 (ru) |
| AU (1) | AU2017238300A1 (ru) |
| BR (1) | BR112018069284A2 (ru) |
| CA (1) | CA3018625A1 (ru) |
| DK (1) | DK3432899T3 (ru) |
| EA (1) | EA201891908A1 (ru) |
| ES (1) | ES2873889T3 (ru) |
| HR (1) | HRP20211173T1 (ru) |
| HU (1) | HUE055635T2 (ru) |
| IL (1) | IL261932B2 (ru) |
| MA (1) | MA43488B1 (ru) |
| MX (1) | MX2018011593A (ru) |
| MY (1) | MY193275A (ru) |
| PE (1) | PE20190432A1 (ru) |
| PH (1) | PH12018502042A1 (ru) |
| PL (1) | PL3432899T3 (ru) |
| PT (1) | PT3432899T (ru) |
| RS (1) | RS62101B1 (ru) |
| RU (1) | RU2767967C2 (ru) |
| SI (1) | SI3432899T1 (ru) |
| UA (1) | UA127180C2 (ru) |
| WO (1) | WO2017162683A1 (ru) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201800002052A1 (it) * | 2018-01-26 | 2019-07-26 | Girolamo Stefano Di | Probiotico per il trattamento della psoriasi |
| EP3851115A1 (en) * | 2020-01-15 | 2021-07-21 | Biopolis, S.L. | Probiotic composition for its use as an antioxidant |
| US20210275612A1 (en) * | 2020-03-09 | 2021-09-09 | Glac Biotech Co., Ltd. | Method for alleviating inflammation-related disorder |
| CN113142554A (zh) * | 2020-06-09 | 2021-07-23 | 江苏佰澳达生物科技有限公司 | 一种改善头皮屑产生的益生菌发酵液及其应用 |
| EP3967318A1 (en) * | 2020-09-14 | 2022-03-16 | Bionou Research, S.L. | Probiotic compositions for the treatment of acne |
| CN112159778B (zh) * | 2020-09-30 | 2021-12-03 | 江南大学 | 一株可缓解银屑病的动物双歧杆菌及其应用 |
| WO2022090474A1 (en) * | 2020-10-29 | 2022-05-05 | Deerland Probiotics & Enzymes A/S | Microencapsulated microbial composition |
| CN112546074B (zh) * | 2020-12-24 | 2022-09-27 | 江南大学 | 一株能够抑制IL-23、Th17轴相关炎症因子释放的短双歧杆菌及其应用 |
| CN112812989B (zh) * | 2020-12-31 | 2022-06-10 | 江南大学 | 一种能够缓解银屑病的青春双歧杆菌及其应用 |
| CN113088473B (zh) * | 2021-04-27 | 2022-08-02 | 江南大学 | 一株具有缓解HaCaT细胞氧化损伤作用的动物双歧杆菌 |
| CN113455549B (zh) * | 2021-06-29 | 2022-09-13 | 黑龙江飞鹤乳业有限公司 | 一种奶酪产品及其制备方法和应用 |
| WO2023111270A1 (en) * | 2021-12-16 | 2023-06-22 | Biopolis, S. L. | Use of postbiotics in the treatment and/or prevention of anxiety disorders |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1635897A (zh) * | 2002-02-21 | 2005-07-06 | 雀巢产品有限公司 | 用于皮肤的可口服的光保护组合物 |
| JP2004250337A (ja) | 2003-02-18 | 2004-09-09 | Sunstar Inc | アレルギー疾患改善用製剤 |
| CN101384269B (zh) * | 2005-10-06 | 2012-11-14 | 普罗比公司 | 乳酸杆菌用于治疗病毒感染的用途 |
| RU2440123C2 (ru) * | 2005-10-06 | 2012-01-20 | Проби Аб | Применение lactobacillus для лечения вирусных инфекций |
| ES2343499B1 (es) * | 2007-12-24 | 2011-06-10 | Consejo Superior De Investigaciones Cientificas | Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten. |
| US20140065209A1 (en) * | 2011-05-03 | 2014-03-06 | Dupont Nutrition Biosciences Aps | Probiotic bacteria for the topical treatment of skin disorders |
| KR20130049554A (ko) | 2011-11-04 | 2013-05-14 | 주식회사 쎌바이오텍 | 아토피 예방 또는 치료용 조성물 |
| KR101453982B1 (ko) * | 2012-09-19 | 2014-10-28 | 주식회사 쎌바이오텍 | 과민성 대장 증후군 예방 또는 치료용 조성물 |
| ES2526986B1 (es) * | 2013-07-18 | 2015-11-02 | Biopolis, S.L. | Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas |
| KR101724601B1 (ko) | 2014-11-04 | 2017-04-10 | 주식회사 쎌바이오텍 | 아토피 예방 또는 치료용 조성물 |
| ES2575828B1 (es) * | 2014-12-31 | 2017-07-07 | Universidad De León | Empleo de probióticos en el incremento de la fertilidad masculina |
| TWI829098B (zh) * | 2015-01-02 | 2024-01-11 | 美商梅拉洛伊卡公司 | 細菌組成物 |
-
2016
- 2016-03-21 EP EP16382122.6A patent/EP3222282A1/en not_active Withdrawn
-
2017
- 2017-03-20 AR ARP170100679A patent/AR107921A1/es unknown
- 2017-03-21 RU RU2018136939A patent/RU2767967C2/ru active
- 2017-03-21 EP EP17722689.1A patent/EP3432899B1/en active Active
- 2017-03-21 EA EA201891908A patent/EA201891908A1/ru unknown
- 2017-03-21 MY MYPI2018703435A patent/MY193275A/en unknown
- 2017-03-21 CN CN201780030657.4A patent/CN110325198B/zh active Active
- 2017-03-21 BR BR112018069284-0A patent/BR112018069284A2/pt active Search and Examination
- 2017-03-21 KR KR1020187030333A patent/KR102303587B1/ko active IP Right Grant
- 2017-03-21 ES ES17722689T patent/ES2873889T3/es active Active
- 2017-03-21 AU AU2017238300A patent/AU2017238300A1/en active Pending
- 2017-03-21 PE PE2018001857A patent/PE20190432A1/es unknown
- 2017-03-21 PT PT177226891T patent/PT3432899T/pt unknown
- 2017-03-21 MX MX2018011593A patent/MX2018011593A/es unknown
- 2017-03-21 RS RS20210883A patent/RS62101B1/sr unknown
- 2017-03-21 DK DK17722689.1T patent/DK3432899T3/da active
- 2017-03-21 WO PCT/EP2017/056719 patent/WO2017162683A1/en active Application Filing
- 2017-03-21 UA UAA201810096A patent/UA127180C2/uk unknown
- 2017-03-21 CA CA3018625A patent/CA3018625A1/en active Pending
- 2017-03-21 IL IL261932A patent/IL261932B2/en unknown
- 2017-03-21 PL PL17722689T patent/PL3432899T3/pl unknown
- 2017-03-21 MA MA43488A patent/MA43488B1/fr unknown
- 2017-03-21 HU HUE17722689A patent/HUE055635T2/hu unknown
- 2017-03-21 SI SI201730861T patent/SI3432899T1/sl unknown
- 2017-03-21 US US16/087,584 patent/US10912802B2/en active Active
-
2018
- 2018-09-24 PH PH12018502042A patent/PH12018502042A1/en unknown
-
2021
- 2021-07-22 HR HRP20211173TT patent/HRP20211173T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018136939A (ru) | Применение пробиотиков для лечения и/или профилактики псориаза | |
| HRP20210995T1 (hr) | Uporaba probiotika u liječenju i/ili prevenciji atopičnog dermatitisa | |
| JP6153517B2 (ja) | ビフィドバクテリウム・ラクティスｂｌ−０４による呼吸器疾患の治療 | |
| Fooks et al. | Probiotics as modulators of the gut flora | |
| EP2990045B1 (en) | Bifidobacterium animalis subsp. lactis for use in decreasing abdominal pain in a postmenopausal woman | |
| Żukiewicz-Sobczak et al. | Probiotic lactic acid bacteria and their potential in the prevention and treatment of allergic diseases | |
| EP2586448B1 (en) | Skin properties improving agent for oral administration | |
| RU2004128078A (ru) | Светозащитная, предназначенная для орального приема композиция для кожи | |
| RU2004127986A (ru) | Оральная композиция для фотопротекции кожи | |
| US10052354B2 (en) | Anti-allergic composition | |
| Gupta et al. | 'Lactic Acid Bacteria: Probiotic Characteristic, Selection Criteria, and its Role in Human Health (A Review)' | |
| JP4486957B2 (ja) | 虫歯および虫歯を惹起する細菌を低減するための乳酸菌の使用 | |
| WO2007010977A1 (ja) | 新規ビフィドバクテリウム属細菌及びその利用 | |
| Otles et al. | Probiotics and health | |
| WO2021256476A1 (ja) | 乳酸菌の胃液・胆汁耐性向上方法 | |
| CN103180432A (zh) | 制备耐贮存益生菌食品的方法 | |
| Balgir et al. | In vitro and in vivo survival and colonic adhesion of Pediococcus acidilactici MTCC5101 in human gut | |
| Kailasapathy | Commercial sources of probiotic strains and their validated and potential health benefits-a review | |
| JP2007082403A (ja) | ユッカ抽出物、キラヤ抽出物及び乳酸菌の複合組成物を含有する飲食品及びその製造法 | |
| JP6945888B1 (ja) | 免疫機能向上用組成物 | |
| Mancuskova et al. | The medical functions of probiotics and their role in clinical nutrition | |
| TWM487084U (zh) | 包覆乳酸菌之微膠囊結構體 | |
| Renuka et al. | Delivery of Probiotics in the Food Industries | |
| Chukwu et al. | Role of anaerobes as probiotic organisms | |
| Abdallah et al. | Antibacterial effects of probiotics isolated from milk products against some common bacterial pathogens |